Press Releases

KING OF PRUSSIA, Pa., July 26, 2019 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE: UHT) announced today that for the three-month period ended June 30, 2019, reported net income was $4.3 million, or $.31 per diluted share, as compared to $5.8 million, or

WARSAW, Ind., July 26, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended June 30, 2019.  The Company reported second quarter net sales of $1.989 billion, a decrease of 0.9% from the prior year period, and an increase of 1.2% on a constant currency basi

SHORT HILLS, N.J., July 26, 2019 /PRNewswire/ -- In celebration of the anniversary of the Americans with Disabilities Act (ADA), the Christopher & Dana Reeve Foundation, the leading nonprofit dedicated to improving quality of life for people living with paralysis, announced today a partnership with Google Nest to improve independence for the greater paralysis c

COLUMBUS, Ohio, July 26, 2019 /PRNewswire/ -- In its quest to end cancer, leading non-profit, Pelotonia, today announced a landmark donation to The Ohio State University

COLUMBUS, Ohio, July 25, 2019 /PRNewswire/ -- AARP Ohio Advocacy & Communications Manager Luke Russell issued the following statement today, applauding Senator Rob Portman and Senator Sherrod Brown for voting in favor of the Senate Finance Committee's Prescription Drug

GERMANTOWN, Md., July 25, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR) ("Neuralstem" or the "Company") today announced the pricing of its underwritten public offering of an aggregate of 2,777,777 units at a public offering price of $2.70 per unit for gross proceeds of approximately $7,500,000, before ded

SAN FRANCISCO, July 25, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP notifies investors in CannTrust Holdings Inc. (NYSE: CTST) of the Expanded Class Period (November 14, 2018 – July 12, 2019) and reminds them of the Lead Plaintiff deadline.

OKLAHOMA CITY, July 25, 2019 /PRNewswire/ -- Progentec, a leader in the development of technological innovations in the field of diagnostics, today announced it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID). The grant funds will be released in two installments starting

RIDGEFIELD, Conn., July 25, 2019 /PRNewswire/ -- Boehringer Ingelheim today announced that the FDA's Arthritis Advisory Committee recommended (10-7 vote) to approve Ofev® (nintedanib) for the treatment of systemic sclerosis associated interstitial lung disease, or SSc-ILD.

VAUGHAN, ON, July 25, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST